Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

Similar articles for PubMed (Select 17322897)

1.

Humanization of autoantigen.

Nishie W, Sawamura D, Goto M, Ito K, Shibaki A, McMillan JR, Sakai K, Nakamura H, Olasz E, Yancey KB, Akiyama M, Shimizu H.

Nat Med. 2007 Mar;13(3):378-83. Epub 2007 Feb 25.

PMID:
17322897
2.

A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.

Ujiie H, Shibaki A, Nishie W, Sawamura D, Wang G, Tateishi Y, Li Q, Moriuchi R, Qiao H, Nakamura H, Akiyama M, Shimizu H.

J Immunol. 2010 Feb 15;184(4):2166-74. doi: 10.4049/jimmunol.0903101. Epub 2010 Jan 20.

3.

[Novel animal models for bullous pemphigoid utilized by "humanization of autoantigen"].

Nishie W, Shimizu H.

Nihon Rinsho Meneki Gakkai Kaishi. 2009 Dec;32(6):472-7. Review. Japanese.

4.

Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.

Natsuga K, Nishie W, Shinkuma S, Ujiie H, Nishimura M, Sawamura D, Shimizu H.

J Immunol. 2012 Jun 1;188(11):5792-9. doi: 10.4049/jimmunol.1003402. Epub 2012 Apr 20.

5.

Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.

Ujiie H, Shibaki A, Nishie W, Shinkuma S, Moriuchi R, Qiao H, Shimizu H.

Clin Immunol. 2012 Feb;142(2):167-75. doi: 10.1016/j.clim.2011.10.002. Epub 2011 Oct 17.

PMID:
22044750
7.

A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies.

Nishie W, Sawamura D, Natsuga K, Shinkuma S, Goto M, Shibaki A, Ujiie H, Olasz E, Yancey KB, Shimizu H.

J Immunol. 2009 Sep 15;183(6):4088-93. doi: 10.4049/jimmunol.0800389. Epub 2009 Aug 28.

8.

Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice.

Hirose M, Recke A, Beckmann T, Shimizu A, Ishiko A, Bieber K, Westermann J, Zillikens D, Schmidt E, Ludwig RJ.

J Immunol. 2011 Aug 1;187(3):1176-83. doi: 10.4049/jimmunol.1100596. Epub 2011 Jun 24.

9.

Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model.

Di Zenzo G, Calabresi V, Olasz EB, Zambruno G, Yancey KB.

J Invest Dermatol. 2010 Apr;130(4):1040-7. doi: 10.1038/jid.2009.309. Epub 2009 Oct 8.

10.

Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid.

Yamamoto K, Inoue N, Masuda R, Fujimori A, Saito T, Imajoh-Ohmi S, Shinkai H, Sakiyama H.

J Invest Dermatol. 2002 Mar;118(3):485-92.

11.

Pathogenesis of bullous pemphigoid.

Ujiie H, Nishie W, Shimizu H.

Immunol Allergy Clin North Am. 2012 May;32(2):207-15, v. doi: 10.1016/j.iac.2012.04.001. Epub 2012 Apr 17.

PMID:
22560134
12.

Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies.

Nishie W.

Methods Mol Biol. 2013;961:363-9. doi: 10.1007/978-1-62703-227-8_24.

PMID:
23325657
13.

What's new in bullous pemphigoid.

Ujiie H, Shibaki A, Nishie W, Shimizu H.

J Dermatol. 2010 Mar;37(3):194-204. doi: 10.1111/j.1346-8138.2009.00792.x. Review.

PMID:
20507382
14.

Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.

Nishie W.

J Dermatol Sci. 2014 Mar;73(3):179-86. doi: 10.1016/j.jdermsci.2013.12.001. Epub 2013 Dec 27. Review.

PMID:
24434029
16.

Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.

Ujiie H, Sasaoka T, Izumi K, Nishie W, Shinkuma S, Natsuga K, Nakamura H, Shibaki A, Shimizu H.

J Immunol. 2014 Nov 1;193(9):4415-28. doi: 10.4049/jimmunol.1400095. Epub 2014 Sep 26.

PMID:
25261486
17.

Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.

Leighty L, Li N, Diaz LA, Liu Z.

Arch Dermatol Res. 2007 Nov;299(9):417-22. Epub 2007 Sep 19. Review.

18.

Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.

Wu Y, Sun NN, Dang EL, Jin L, Liu ZF, Zhang W, Yang LT, Wang G.

J Dermatol Sci. 2013 Oct;72(1):25-31. doi: 10.1016/j.jdermsci.2013.05.010. Epub 2013 Jun 13.

PMID:
23827201
20.

An animal model of bullous pemphigoid: what can it teach us?

Giudice GJ, Liu Z, Diaz LA.

Proc Assoc Am Physicians. 1995 Jul;107(2):237-41. Review.

PMID:
8624858
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk